Johnson & Johnson aims to produce 1 billion coronavirus vaccines by next year

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. - The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP via Getty Images)

Healthcare giant Johnson & Johnson is looking to produce a billion coronavirus vaccines for next year, according to Dr. Paul Stoffels, the company’s chief scientific officer.

“We start clinical trials in September and hopefully have data by the end of the year,” Stoffels said Sunday on ABC, adding that the company is “now working towards one billion vaccines for next year.”

Johnson & Johnson is upscaling manufacturing and will start producing the vaccine later this year, he said.

Stoffels said, “clinical trials will need to be done to show that it is effective, and that will take some time.”

He added: “We will have some vaccine available this year, but it will depend on the authorities – the FDA and others – to decide whether it can be used earlier before efficacy data are available.”

Check Also

Iraqi PM addresses negligence and promises care for Al-Hamdaniyah incident victims

The Iraqi Prime Minister Mohammad Shia Al-Sudani has made a statement regarding the tragic Al-Hamdaniyah …

Leave a Reply

Your email address will not be published. Required fields are marked *